2019/06/08：冷泉港亚洲-癌症免疫学的科学和技术进展

Organized by:

Ira Mellman, University of California San Francisco/Genentech, USA

Zemin Zhang, Peking University, China

Major Topics:
1. Clinical advances in cancer immunotherapies
2. New target identification for cancer immunotherapies
3. T cell biology, checkpoint blockade, and CAR-T
4. The tumor microenvironment: imaging and cell-cell interaction
5. Myeloid cells and cancer
6. Single cell sequencing and tumor immunology
7. Tumor immunogenomics and large-scale biology

Keynote Speaker (Speaker, Affiliation, COUNTRY/Region）:
Alexander Rudensky, Memorial Sloan Kettering Cancer Center, USA

Invited Speakers (Speaker, Affiliation, COUNTRY/Region）:
Rafi Ahmed , Emory University, USA
Tara Arvedson, Oncology Research, Amgen, USA
Xuetao Cao, Nankai University, CHINA
Sebastian Carotta, Boehringer Ingelheim, Austria
Chen Dong, Tsinghua University, CHINA
Yang-Xin Fu, UT Southwestern Medical Center, USA
Ronald Germain, National Institutes of Health, USA
Florent Ginhoux, SINGAPORE IMMUNOLOGY NETWORK (SIgN), A*STAR, Singapore
Muzlifah Haniffa, Newcastle University, UK
Vijay Kuchroo, Harvard Medical School & Brigham and Women’s Hospital, USA
Ira Mellman, University of California, San Francisco/Genentech,
Wenjun Ouyang, Amgen, USA
Woong-Yang Park, Samsung Medical Center, South Korea
Shyam Prabhakar, Genome Institute of Singapore, SINGAPORE
Bing Su, Shanghai Jiao Tong University School of Medicine, China
Eric Tran, Providence Portland Medical Center, USA
Shannon Turley, Genentech, USA
E. John Wherry, University of Pennsylvania, USA
Meng Michelle Xu, Tsinghua University, China
Zemin Zhang, Peking University, CHINA

会务组电话：0512-62729029

会务组邮箱：meetings@csh-asia.org

详情请点击官网：http://www.csh-asia.org/2019meetings/immune.html